Cash-strapped Zoono seeks A$2.1m from rights issue

Cash-strapped Zoono seeks A$2.1m from rights issue
Hand and surface sanitisers were in demand during the pandemic. (Image: Getty)
Denise McNabb
After continuing to burn cash and as its revenue plunges, Zoono Group plans to raise A$2.1 million (NZ$2.2m) through a pro-rata rights issue with free options to fund projects, a joint venture with Douglas Pharmaceuticals, China expansion and working capital. The Australian stock exchange-listed New Zealand manufacturer of antimicrobial hand and surface sanitisers announced the share offer in tandem with the release of its March 31 third-quarter report.The report details a dire future for the company unless it changes direction away from e...

More Markets

Mercury announces reshuffle at its top table
Finance

Mercury announces reshuffle at its top table

The two new members of the executive team are internal candidates.

Cuncannon: building a plaintiff side law firm
Markets

Cuncannon: building a plaintiff side law firm

The class action industry in New Zealand is somewhat underdeveloped.

Why Ebos is hunting SMEs
Markets

Why Ebos is hunting SMEs

What's next for Ebos after the end of that Chemist Warehouse contract.

Spark outlines more possible asset sales
Finance

Spark outlines more possible asset sales

The Spark board has a calculation to make about dividend reinvestment policy.